188 results on '"Kang, Yu Mi"'
Search Results
2. The Impact of Fasciation on Maize Inflorescence Architecture
3. Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study
4. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study
5. Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
6. The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects
7. Association between serum gamma-glutamyltransferase and the progression of coronary artery calcification
8. Dehydroepiandrosterone prevents linoleic acid-induced endothelial cell senescence by increasing autophagy
9. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
10. 19-LB: The Impact of Diabetes on 30-Day Readmission, In-Hospital Mortality, and Medical Cost in ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention—A Nationwide Readmissions Database Analysis
11. The Survival Role of Peroxisome Proliferator-activated Receptor Gamma Induces Odontoblast Differentiation against Oxidative Stress in Human Dental Pulp Cells
12. Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study
13. Life Span and Thymic Lymphoma Incidence in High- and Low-Dose-Rate Irradiated AKR/J Mice and Commonly Expressed Genes
14. Ralstonia solanacearum Type III Effector RipJ Triggers Bacterial Wilt Resistance in Solanum pimpinellifolium
15. The Risk of Incident Type 2 Diabetes in a Korean Metabolically Healthy Obese Population: The Role of Systemic Inflammation
16. Association of Serum C1q/TNF-Related Protein-9 Concentration With Arterial Stiffness in Subjects With Type 2 Diabetes
17. 1014-P: The Impact of Baseline A1C and Admission Glucose on Mortality among Patients with Diabetes Hospitalized with COVID-19
18. Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19
19. SGLT2 INHIBITORS AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES AT HIGH RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, HEART FAILURE OR CHRONIC KIDNEY DISEASE: A SMART-C COLLABORATIVE META-ANALYSIS.
20. MON-LB035 Adrenal Venous Sampling in the Lateralization of Acth-Independent Cushing Syndrome With Bilateral Adrenal Masses: A Case With a 5-Year Follow-Up
21. Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
22. 1341-P: Association of NAFLD with Diabetes and the Impact of Waist Circumference and BMI Changes in Subjects with Prediabetes
23. The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects
24. Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
25. Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
26. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese state
27. Cardiovascular multimorbidity and life expectancy in 41161 type 2 diabetic adults: a Korean national sample cohort study
28. Transplantation of human mobilized mononuclear cells improved diabetic neuropathy
29. The Impact of Fatty Liver Disease and Metabolic Syndrome on the Progression of Coronary Artery Calcification
30. Identification of Subpopulations Exhibiting the Greatest Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide-1 Receptor Agonists—A Combined Analysis of Large Cardiovascular Outcome Trials
31. Effect of SFRP5 (Secreted Frizzled–Related Protein 5) on the WNT5A (Wingless-Type Family Member 5A)-Induced Endothelial Dysfunction and Its Relevance With Arterial Stiffness in Human Subjects
32. Comparison between sodium-glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta-analysis
33. Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice
34. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype
35. Evaluation of Water Quality Characteristics of Floor Fountains in Gwangju
36. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
37. Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
38. Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
39. Mortality and causes of death from 2002 to 2013 in a national sample of diabetic patients in Korea
40. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype
41. Senp2 expression was induced by chronic glucose stimulation in INS1 cells, and it was required for the associated induction of Ccnd1 and Mafa
42. Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013
43. 2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population
44. The association of incident hypertension with metabolic health and obesity status: definition of metabolic health does not matter
45. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity
46. C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells
47. Mechanism of Hypoglycemia-Associated Cardiovascular Diseases
48. Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
49. Abstract 13300: The Risk of Incident Hypertension According to the Metabolic Health and Obesity: Definition of Metabolic Health Does Not Matter
50. The risk of chronic kidney disease in a metabolically healthy obese population
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.